A 1-Year Study On The Effects Of CP-945,598 For The Treatment Of Obesity In Overweight Type 2 Diabetic Patients

This study has been terminated.

( See termination reason in detailed description. )

Study NCT00391196 Information provided by Pfizer

First Received: October 19, 2006 Last Updated: October 27, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Obesity

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Placebo
CP-945,598
CP-945,598 Treatment B

Sponsors listed in this trial

Pfizer